APXT
Apex Treasury Corporation Class A
There isn't enough reported data to score APXT yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
APXT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
APXT's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like APXT.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
APXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 50x | $10.21 | — |
| Cheap | 85x | $16.96 | +66% |
| Fair | 86x | $17.10 | +68% |
| Expensive | 108x | $21.52 | +111% |
Historical ranges are pointers, not guarantees.
APXT has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
APXT Forward outlook
There aren't enough analyst estimates for APXT to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
APXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.20 | +$1.34 |
| Q2 2026 | $0.16 | +$1.29 |
| Q1 2026 | $0.12 | +$1.32 |
APXT has returned to profit: it earned $0.20 per share over the past year, after losing money the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over APXT in the latest year-over-year earnings comparison.
APXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $114.7M | -60% |
APXT's revenue has slid since its 2024 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 13% | +5.5 points |
| Q1 2025 | 3.5% | +28 points |
| Q4 2024 | 7.2% | N/A |
| Q3 2024 | 8.6% | N/A |
| Q2 2024 | -2.7% | N/A |
| Q2 2021 | -24% | N/A |
APXT's operating margin was 13% last quarter, up 15 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over APXT in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
APXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$211.7K | -$211.7K |
| Q2 2026 | -$23.4M | -228% |
| Q1 2026 | $23M | +$24M |
| Q4 2025 | $29M | -66% |
| Q3 2025 | $0 | -100% |
| Q2 2021 | -$243 | +$210.3K |
| Q1 2021 | -$358.1K | +$24.8K |
| Q2 2020 | -$210.5K | -$210.5K |
APXT has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
APXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +33% | +11.5M shares |
| 1 year | +360% | +36M shares |
| 3 years | +3.1% | +1.4M shares |
APXT has 46M diluted shares, up 360% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $59.8M |
| Q1 2026 | $59.8M |
| Q4 2025 | — |
| Q2 2025 | $19M |
| Q1 2025 | $11.9M |
| Q4 2024 | $33.1M |
| Q3 2024 | $21.7M |
| Q2 2021 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over APXT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
APXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -40.5x | Net Cash |
| Q1 2025 | -41.4x | Net Cash |
APXT has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like APXT.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
APXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.7 | Overbought |
| Stochastic | 80.0 | Overbought |
APXT's weekly RSI is 76 (overbought) and its Stochastic is 80 (overbought).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
APXT PE vs Financial Services Sector
| Metric | APXT | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 13x | 287% above |
| PE % | 0 | 12 | 12 pts below |
APXT is trading at 50x earnings, a 287% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over APXT on valuation relative to its sector.
APXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 0.5% above |
| 20 week MA | $10.1 | 0.8% above |
| 50 week MA | $10.0 | 1.8% above |
APXT has stronger trend alignment. APXT is above 3 of 3 weekly averages versus JPM above 4 of 5.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
APXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $9.89 | $9.88 | -0.1% |
| 2026 YTD | $9.88 | $10.2 | +3.3% |
APXT has finished every year since 2025 lower, and it's up 3.3% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over APXT on returns for 2026, with the stronger performance.